• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为雄激素源和靶器官的阴道:治疗 GSM/VVA 的意义,包括 DHEA。

The vagina as source and target of androgens: implications for treatment of GSM/VVA, including DHEA.

机构信息

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Florence, Italy.

Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.

出版信息

Climacteric. 2023 Aug;26(4):309-315. doi: 10.1080/13697137.2023.2213827. Epub 2023 Jun 8.

DOI:10.1080/13697137.2023.2213827
PMID:37288964
Abstract

The vagina is traditionally thought of as a passive organ in the female reproductive system, serving primarily as a passageway for menstrual blood, sexual intercourse and childbirth. However, recent research has shed light on the vagina's role as an endocrine organ that plays a crucial role in female hormonal balance and overall health. Particularly, growing evidence shows that the human vagina can be considered both as source and target of androgens, in view of the novel concept of 'intracrinology'. Besides the well-known role of estrogens, androgens are also crucial for the development and maintenance of healthy genitourinary tissues in women. As androgen levels decline with age, and estrogen levels fall during the menopausal transition, the tissues in the vagina, together with those in the urinary tract, become thinner, drier and less elastic, leading to a variety of uncomfortable and sometimes painful symptoms, clustered in the genitourinary syndrome of menopause (GSM). Given the lack of testosterone-based or androstenedione-based products approved by regulatory agencies to treat GSM, the possibility of using intravaginal prasterone, which works by providing a local source of dehydroepiandrosterone (DHEA) to the vaginal tissues, appears to be a targeted treatment. Further studies are needed to better assess its safety and efficacy.

摘要

传统上,阴道被认为是女性生殖系统中的一个被动器官,主要作为月经血、性行为和分娩的通道。然而,最近的研究揭示了阴道作为内分泌器官的作用,它在女性激素平衡和整体健康中起着至关重要的作用。特别是,越来越多的证据表明,鉴于“胞内学科”的新概念,人类阴道可以被视为雄激素的来源和靶器官。除了众所周知的雌激素作用外,雄激素对女性泌尿生殖组织的发育和维持也至关重要。随着年龄的增长,雄激素水平下降,而在绝经过渡期间雌激素水平下降,阴道组织以及尿路组织变得更薄、更干燥且弹性更小,导致出现各种不适甚至有时是疼痛的症状,这些症状聚集在绝经后泌尿生殖系统综合征(GSM)中。由于缺乏经监管机构批准的基于睾酮或雄烯二酮的产品来治疗 GSM,因此使用阴道内普拉睾酮的可能性似乎是一种有针对性的治疗方法,它通过向阴道组织提供局部脱氢表雄酮(DHEA)的来源起作用。需要进一步的研究来更好地评估其安全性和疗效。

相似文献

1
The vagina as source and target of androgens: implications for treatment of GSM/VVA, including DHEA.作为雄激素源和靶器官的阴道:治疗 GSM/VVA 的意义,包括 DHEA。
Climacteric. 2023 Aug;26(4):309-315. doi: 10.1080/13697137.2023.2213827. Epub 2023 Jun 8.
2
An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause.脱氢表雄酮(EM-760)作为治疗绝经后泌尿生殖系统综合征的一种选择的概述。
Expert Opin Pharmacother. 2020 Mar;21(4):409-415. doi: 10.1080/14656566.2019.1703951. Epub 2020 Jan 11.
3
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.阴道用脱氢表雄酮(DHEA)治疗中重度性交痛和阴道干燥、外阴阴道萎缩症状以及绝经后泌尿生殖系统综合征的疗效。
Menopause. 2018 Nov;25(11):1339-1353. doi: 10.1097/GME.0000000000001238.
4
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.阴道内使用脱氢表雄酮(DHEA)对中度至重度性交困难和阴道干燥、外阴阴道萎缩症状以及绝经后泌尿生殖综合征的疗效。
Menopause. 2016 Mar;23(3):243-56. doi: 10.1097/GME.0000000000000571.
5
Prasterone: A Review in Vulvovaginal Atrophy.普拉睾酮:治疗外阴阴道萎缩的研究进展。
Drugs Aging. 2019 Aug;36(8):781-788. doi: 10.1007/s40266-019-00693-6.
6
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.性交困难对绝经后妇女阴道用普拉睾酮(脱氢表雄酮,DHEA)治疗性功能障碍有益效果无影响。
J Sex Med. 2014 Jul;11(7):1766-85. doi: 10.1111/jsm.12517. Epub 2014 Apr 28.
7
The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.雄激素在女性泌尿生殖系统综合征(GSM)治疗中的作用:国际女性性健康学会(ISSWSH)专家共识小组的审查。
Menopause. 2018 Jul;25(7):837-847. doi: 10.1097/GME.0000000000001138.
8
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.阴道内用普拉睾酮治疗中重度性交困难:综述。
Climacteric. 2019 Feb;22(1):65-72. doi: 10.1080/13697137.2018.1535583. Epub 2018 Dec 17.
9
Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.阴道内使用6.5毫克(0.50%)普拉睾酮、0.3毫克结合雌激素和10微克雌二醇对外阴阴道萎缩症状的比较。
J Steroid Biochem Mol Biol. 2017 Nov;174:1-8. doi: 10.1016/j.jsbmb.2017.03.014. Epub 2017 Mar 18.
10
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.阴道内使用普拉睾酮对绝经后外阴阴道萎缩女性性功能障碍的影响。
J Sex Med. 2015 Dec;12(12):2401-12. doi: 10.1111/jsm.13045. Epub 2015 Nov 23.